Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Y Li; X Wang; E O'Mara; MA Dimopoulos; Pieter Sonneveld; KC Weisel; J Matous; DS Siegel; JJ Shah; E Kueenburg; L Sternas; C Cavanaugh; M Zaki; M Palmisano; S Zhou

doi:10.2147/cpaa.s144606

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Y Li, X Wang, E O'Mara, MA Dimopoulos, Pieter Sonneveld, KC Weisel, J Matous, DS Siegel, JJ Shah, E Kueenburg, L Sternas, C Cavanaugh, M Zaki, M Palmisano, S Zhou

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

18 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	133-145
Number of pages	13
Journal	Clinical Pharmacology-Advances and Applications
Volume	9
DOIs	https://doi.org/10.2147/cpaa.s144606
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.2147/cpaa.s144606

REPUB_103165-OA.pdfFinal published version, 1.9 MB

http://hdl.handle.net/1765/103165

Cite this

Li, Y., Wang, X., O'Mara, E., Dimopoulos, MA., Sonneveld, P., Weisel, KC., Matous, J., Siegel, DS., Shah, JJ., Kueenburg, E., Sternas, L., Cavanaugh, C., Zaki, M., Palmisano, M., & Zhou, S. (2017). Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function. Clinical Pharmacology-Advances and Applications, 9, 133-145. https://doi.org/10.2147/cpaa.s144606

@article{bea137dc500049698d4112f99dae380b,

title = "Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function",

author = "Y Li and X Wang and E O'Mara and MA Dimopoulos and Pieter Sonneveld and KC Weisel and J Matous and DS Siegel and JJ Shah and E Kueenburg and L Sternas and C Cavanaugh and M Zaki and M Palmisano and S Zhou",

year = "2017",

doi = "10.2147/cpaa.s144606",

language = "Undefined/Unknown",

volume = "9",

pages = "133--145",

journal = "Clinical Pharmacology-Advances and Applications",

issn = "1179-1438",

publisher = "Dove Medical Press Ltd",

}

Li, Y, Wang, X, O'Mara, E, Dimopoulos, MA, Sonneveld, P, Weisel, KC, Matous, J, Siegel, DS, Shah, JJ, Kueenburg, E, Sternas, L, Cavanaugh, C, Zaki, M, Palmisano, M & Zhou, S 2017, 'Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function', Clinical Pharmacology-Advances and Applications, vol. 9, pp. 133-145. https://doi.org/10.2147/cpaa.s144606

TY - JOUR

T1 - Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

AU - Li, Y

AU - Wang, X

AU - O'Mara, E

AU - Dimopoulos, MA

AU - Sonneveld, Pieter

AU - Weisel, KC

AU - Matous, J

AU - Siegel, DS

AU - Shah, JJ

AU - Kueenburg, E

AU - Sternas, L

AU - Cavanaugh, C

AU - Zaki, M

AU - Palmisano, M

AU - Zhou, S

PY - 2017

Y1 - 2017

U2 - 10.2147/cpaa.s144606

DO - 10.2147/cpaa.s144606

M3 - Article

SN - 1179-1438

VL - 9

SP - 133

EP - 145

JO - Clinical Pharmacology-Advances and Applications

JF - Clinical Pharmacology-Advances and Applications

ER -